Anti-CD47 Antibodies Destroys a Variety of Human Cancers Study to Advance to Human Trials...

"It is the first antibody treatment shown to be broadly effective against a variety of human solid tumors, and the dramatic response — including some overt cures in the laboratory animals — has the investigators eager to begin phase-1 and –2 human clinical trials within the next two years..."
http://med.stanford.edu/ism/2012/march/cd47.html
(Click link to story)